COMMUNIQUÉS West-GlobeNewswire

Now Available: 1G Live Resin THCA Disposable By The Hemp Doctor
09/01/2026
MOORESVILLE, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Trusted by customers for high-quality hemp-derived THC products and vapes since 2018, The Hemp Doctor launches its newest innovation: the ZOOTED | THCA Live Resin 1G [...]
O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated
09/01/2026
Data from the first in human study on O3R-5671’s potent TNFα inhibition to be presented Dosing of the final cohort in the first in human study has been initiated Studies in ulcerative colitis and psoriasis to initiate [...]
Allegro to start production of osteoarthritis hydrogel as it prepares for clinical trials
09/01/2026
Wallonia Minister of Economy and Employment Pierre-Yves Jeholet will perform opening ceremony on 9 January 2026 New cleanroom facility allows production of one million doses per year Ramping up for clinical development [...]
Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy
09/01/2026
Press release – No. 2 / 2026 Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy Access to Gefion, Denmark’s flagship AI [...]
Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
09/01/2026
Saint Herblain (France), January 09, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that members of its management team will meet one-on-one with existing [...]
Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference
09/01/2026
Saint Herblain (France), le 9 janvier 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui que des membres de son équipe dirigeante rencontreront les [...]
Tecan reports return to sales growth and strong order entry in the second half of 2025
09/01/2026
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan reports return to sales growth and strong order entry in the second half of 2025 Group sales of CHF 882.5 million, down 1.6% [...]
Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering
09/01/2026
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc . (“Monte Rosa”) (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today [...]
AquaFit Weight Loss Supplement Investigation: 2026 Thermogenic Research Examines Green Tea, Berberine, and Metabolic Support Ingredients
09/01/2026
Alpha Lipoic Acid, Chromium, Cayenne, and Korean Ginseng Capsule Analysis Amid January 2026 Natural Weight Loss Supplement Search Trends AURORA, COLORADO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is [...]
"Best Peptides for Hair Growth" Search Trends Surge as Telehealth Platforms Expand FDA-Approved Medication Access in 2026
09/01/2026
January 2026 Consumer Report Examines How PeterMD and Similar Platforms Facilitate Prescription Hair Loss Treatment Access Through Licensed Telehealth Evaluation Vero Beach, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- [...]
"Best Skin Tag Remover" Consumer Search Analysis: Topical Solutions vs Freezing Kits vs Clinical Procedures – NutriDerma Guard Format Overview
09/01/2026
January 2026 Consumer Report: At-Home Skin Tag Removal Format Comparison, Natural Ingredient Profile Context, and Product Selection Considerations for Topical vs Professional Methods Largo, FL, Jan. 08, 2026 (GLOBE [...]
True Keto Fusion Keto+ ACV Gummies: What Consumers Should Know as BHB-ACV Category Expands Into 2026
09/01/2026
An Informational Analysis of True Keto Fusion Gummies, BHB Ketone Salts, Apple Cider Vinegar Gummy Supplements, and Consumer Evaluation Criteria for the Keto ACV Gummies Category in 2026 Chicago, IL, Jan. 08, 2026 ( [...]
ReadyRx Sermorelin: Prescription Telehealth Access in Injectable and ODT Formats — 2026 Platform Analysis of Compounding Standards and Provider Structure
09/01/2026
Market Analysis: How Three-Entity Telehealth Platforms Handle Prescription Peptide Evaluation, Compounded Medication Dispensing, and Realistic Timeline Variability AUSTIN, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Disclaimer: [...]
Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
09/01/2026
Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year Facility NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for [...]
Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary
09/01/2026
Trial to resolve all claims in the Anaptys and Tesaro/GSK dispute is scheduled for July 14-17, 2026 SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company [...]
Best Creatine Supplements for Women And Men 2026: Effective Creatine For Muscle Growth & Weight loss For Women Over 40, 50 - by Crazy Nutrition
08/01/2026
Wondering what the Safe creatines for women in 2026 are? In this guide, a high-performance athlete and nutritionist helps you choose the best creatine for women. New York City,, Jan. 08, 2026 (GLOBE NEWSWIRE) -- In 2026 [...]
SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer
08/01/2026
FORT LAUDERDALE, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII) , a developer of innovative surgical robotic technologies dedicated to [...]
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
08/01/2026
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
Cellectis Announces 2026 Strategy and Catalysts
08/01/2026
NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving [...]

Pages